Literature DB >> 30171964

An epidemiological, developmental and clinical overview of cannabis use during pregnancy.

Hanan El Marroun1, Qiana L Brown2, Ingunn Olea Lund3, Victoria H Coleman-Cowger4, Amy M Loree5, Devika Chawla6, Yukiko Washio7.   

Abstract

The objective of the current narrative literature review is to provide an epidemiological, developmental and clinical overview on cannabis use during pregnancy. Cannabis use in pregnancy poses major health concerns for pregnant mothers and their developing children. Although studies on the short- and long-term consequences of prenatal cannabis exposure are increasing, findings have been inconsistent or difficult to interpret due to methodological issues. Thus, consolidating these findings into clinical recommendations based on the mixed studies in the literature remains a challenge. Synthesizing the available observational studies is also difficult, because some of the published studies have substantial methodological weaknesses. Improving observational studies will be an important step toward understanding the extent to which prenatal exposure to cannabis influences neurodevelopment in the offspring. Therefore, further research on prenatal cannabis exposure and the long-term consequences to offspring health in representative samples are needed to guide and improve clinical care for pregnant women and their children. Future research should also investigate the role of policies on prenatal cannabis use.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cannabis; Clinical medicine; Marijuana abuse; Maternal exposure; Prenatal exposure delayed effects; Preventive medicine

Mesh:

Year:  2018        PMID: 30171964     DOI: 10.1016/j.ypmed.2018.08.036

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  17 in total

1.  Cannabis use among women of reproductive age in the United States: 2002-2017.

Authors:  Omayma Alshaarawy; James C Anthony
Journal:  Addict Behav       Date:  2019-08-07       Impact factor: 3.913

2.  Cannabis legalization and cannabis-involved pregnancy hospitalizations in Colorado.

Authors:  George Sam Wang; Christine Buttorff; Asa Wilks; Daniel Schwam; Torri D Metz; Gregory Tung; Rosalie Liccardo Pacula
Journal:  Prev Med       Date:  2022-02-09       Impact factor: 4.018

3.  Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study.

Authors:  Roman Gabrhelík; Milada Mahic; Ingunn Olea Lund; Jørgen Bramness; Randi Selmer; Eva Skovlund; Marte Handal; Svetlana Skurtveit
Journal:  Eur Addict Res       Date:  2020-10-09       Impact factor: 3.015

4.  Sex-specific behavioural deficits induced at early life by prenatal exposure to the cannabinoid receptor agonist WIN55, 212-2 depend on mGlu5 receptor signalling.

Authors:  Antonia Manduca; Michela Servadio; Francesca Melancia; Sara Schiavi; Olivier J Manzoni; Viviana Trezza
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

5.  Correlates of continued cannabis use during pregnancy.

Authors:  Chelsea K Pike; Michael J Sofis; Alan J Budney
Journal:  Drug Alcohol Depend       Date:  2021-07-30       Impact factor: 4.852

6.  Attitudes and Beliefs Toward Cannabis Before Recreational Legalization: A Cross-Sectional Study of Community Adults in Ontario.

Authors:  Jasmine Turna; Iris Balodis; Michael Van Ameringen; Jason W Busse; James MacKillop
Journal:  Cannabis Cannabinoid Res       Date:  2020-06-02

Review 7.  Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling.

Authors:  Alexis L Franks; Kimberly J Berry; Donald B DeFranco
Journal:  J Neuroendocrinol       Date:  2019-10-02       Impact factor: 3.870

8.  Cannabis use and stressful life events during the perinatal period: cross-sectional results from Pregnancy Risk Assessment Monitoring System (PRAMS) data, 2016.

Authors:  Alicia M Allen; Alesia M Jung; Adam C Alexander; Sharon S Allen; Kenneth D Ward; Mustafa al'Absi
Journal:  Addiction       Date:  2020-03-10       Impact factor: 7.256

9.  Perinatal CBD or THC Exposure Results in Lasting Resistance to Fluoxetine in the Forced Swim Test: Reversal by Fatty Acid Amide Hydrolase Inhibition.

Authors:  Izaque de Sousa Maciel; Gabriel H D de Abreu; Claire T Johnson; Rida Bonday; Heather B Bradshaw; Ken Mackie; Hui-Chen Lu
Journal:  Cannabis Cannabinoid Res       Date:  2021-06-28

10.  Update on the developmental consequences of cannabis use during pregnancy and lactation.

Authors:  Kimberly S Grant; Elizabeth Conover; Christina D Chambers
Journal:  Birth Defects Res       Date:  2020-08-07       Impact factor: 2.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.